<p>(<b>a, b</b>) Immunoblotting and reserve transcription PCR analysis showing the protein and mRNA levels of Nrf2, Keap1, γGCLC and HO-1.Cells were treated with 200 µmol/l urate for 0.5, 3, 6 and 14 hours. <i>β</i>-actin served as loading controls. (<b>c</b>) Effect of urate on Nrf2 protein level in the presence of 1 µg/ml CHX. Cells were harvested and lysed at 0, 10 and 30 min after CHX addition with or without urate treatment. (<b>d</b>) Urate did not disrupt Keap1-Nrf2 complex. Cells were treated with 200 µmol/l urate for 6 h. The association of this complex was assessed using IP with anti-Keap1, followed by immunoblotting with anti-Nrf2. (<b>e</b>) Urate inhibited Nrf2 ubiquitination. Cells were treated with or without urate for 6 h in...
<p>NRK-52E cells were treated with 200μmol/L of uric acid in the absence or presence of NF-κB inhibi...
<p><b>A</b>) Real-time RT-PCR analysis of Nrf2 mRNA measured at various times post-infection of HMVE...
<p><b>A.</b> Nuclear fractions from BEAS2B cells treated with SKI-II (1 µM) at increasing times (10–...
<p>Cells were pre-incubated with urate for 30 min prior to 6-OHDA treatment for 6 h. (<b>a</b>) Repr...
<p>Urate may be accumulated into cells via undefined transporters. It led to Nrf2 accumulation by in...
Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) diagnosis and ...
<p>(<b>a, b</b>) SH-SY5Y cells were transfected with scrambled siRNA (si-control) or two different s...
BACKGROUND: Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) di...
<p>(a through c) Q-PCR results showed that RANTES, MCP-1 and TNF-α mRNA expression were increased in...
<p>(<b>a, c</b>) Concentration-dependent toxicity of H<sub>2</sub>O<sub>2</sub> treatment for 12 h t...
<p>(a) Western blot analysis showed that uric acid induced p65 NF-κB phosphorylation and activation ...
<p>NBT-II cells were co-transfected for 24 h with expression plasmids for Nrf2 (pEF/Nrf2), Keap1 (pc...
<p>(<b>A</b>) Treatment of Min6 cells with 5 mg/dL uric acid for 24 h upregulated NF-κB transcriptio...
<p>(<b>a</b>) Effect of urate pre-treatment on cell viability. Urate was removed by washout after 30...
<p>(a through c) Q-PCR results showed that probenecid inhibits uric acid-induced RANTES (a), MCP-1 (...
<p>NRK-52E cells were treated with 200μmol/L of uric acid in the absence or presence of NF-κB inhibi...
<p><b>A</b>) Real-time RT-PCR analysis of Nrf2 mRNA measured at various times post-infection of HMVE...
<p><b>A.</b> Nuclear fractions from BEAS2B cells treated with SKI-II (1 µM) at increasing times (10–...
<p>Cells were pre-incubated with urate for 30 min prior to 6-OHDA treatment for 6 h. (<b>a</b>) Repr...
<p>Urate may be accumulated into cells via undefined transporters. It led to Nrf2 accumulation by in...
Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) diagnosis and ...
<p>(<b>a, b</b>) SH-SY5Y cells were transfected with scrambled siRNA (si-control) or two different s...
BACKGROUND: Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) di...
<p>(a through c) Q-PCR results showed that RANTES, MCP-1 and TNF-α mRNA expression were increased in...
<p>(<b>a, c</b>) Concentration-dependent toxicity of H<sub>2</sub>O<sub>2</sub> treatment for 12 h t...
<p>(a) Western blot analysis showed that uric acid induced p65 NF-κB phosphorylation and activation ...
<p>NBT-II cells were co-transfected for 24 h with expression plasmids for Nrf2 (pEF/Nrf2), Keap1 (pc...
<p>(<b>A</b>) Treatment of Min6 cells with 5 mg/dL uric acid for 24 h upregulated NF-κB transcriptio...
<p>(<b>a</b>) Effect of urate pre-treatment on cell viability. Urate was removed by washout after 30...
<p>(a through c) Q-PCR results showed that probenecid inhibits uric acid-induced RANTES (a), MCP-1 (...
<p>NRK-52E cells were treated with 200μmol/L of uric acid in the absence or presence of NF-κB inhibi...
<p><b>A</b>) Real-time RT-PCR analysis of Nrf2 mRNA measured at various times post-infection of HMVE...
<p><b>A.</b> Nuclear fractions from BEAS2B cells treated with SKI-II (1 µM) at increasing times (10–...